Drugs / Oxantel Pamoate
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06606860 | Jan → Apr 2025 | — | Swiss Tropical & Public Health Institute | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT06720259 | Apr → May 2025 | ascariasis, hookworm infectious disease, trichuriasis | Jennifer Keiser | Completed | No outcome recorded |
| Phase 41 trial · 1 met primary | ||||||
| Phase 4 | NCT03278431 | Sep → Nov 2017 | hookworm infectious disease | Swiss Tropical & Public Health Institute | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxantel pamoate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03278431 ↗ |
| Route | Oral | “oral administration” NCT06606860 ↗ |